NCT03337750

Brief Summary

It is urgent to make evidence-based treatments (EBTs) for military personnel readily accessible in order to meet the growing demand for effective and efficient treatment for posttraumatic stress disorder (PTSD) in a timely manner. Effective EBTs for PTSD are available, but barriers to accessing care can deter military personnel from receiving treatment. Web-treatments represent an innovative way to overcome these barriers. The efficacy of previously developed web-treatments for PTSD appear promising, however, they are not based on treatment protocols with strong empirical support for their efficacy. No study to date has examined web-treatment of PTSD using a well-established treatment program. The purpose of this open trial is to examine the efficacy of 10 sessions of a web-version of Prolonged Exposure (PE), "Web-PE," delivered over 8-weeks in 40 active-duty military personnel and veterans with PTSD who deployed post 9-11. Up to 60 individuals will be consented to obtain data from 40 for analysis. Participants will be assessed at pre-treatment and 1- and 3-months after treatment completion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 9, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

February 12, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 27, 2019

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 14, 2020

Completed
Last Updated

February 19, 2020

Status Verified

February 1, 2020

Enrollment Period

1.1 years

First QC Date

November 3, 2017

Last Update Submit

February 18, 2020

Conditions

Keywords

CombatPsychological TreatmentMilitaryPsychotherapyTraumaPosttraumatic StressPosttraumatic Stress Disorder

Outcome Measures

Primary Outcomes (1)

  • PTSD CheckList-5 (PCL-5)

    A 20-item self-report measure of PTSD symptoms as defined by the DSM-5. Higher scores indicate greater PTSD symptom severity.

    Change from baseline to 1-month follow-up (post-treatment)

Secondary Outcomes (1)

  • Patient Health Questionnaire-9 (PHQ-9)

    Change from baseline to 1-month follow-up (post-treatment)

Study Arms (1)

Web-PE

EXPERIMENTAL

Ten 60-minute psychotherapy sessions over 8 weeks, focused on gradually confronting distressing trauma-related memories and reminders. Web-PE is an internet-based version of prolonged exposure (PE) for posttraumatic stress disorder (PTSD).

Behavioral: Web-PE Therapy

Interventions

Web-PE TherapyBEHAVIORAL

Ten 60-minute psychotherapy sessions over 8 weeks, focused on gradually confronting distressing trauma-related memories and reminders. Web-PE is an internet-based version of prolonged exposure (PE) for posttraumatic stress disorder (PTSD).

Also known as: Internet-based prolonged exposure
Web-PE

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Active-duty military personnel and veterans who have deployed post 9/11
  • Seeking treatment for PTSD
  • Significant PTSD symptoms as determined by a PCL-5 score greater than or equal to 31
  • Has experienced a Criterion A event that is a specific combat-related event or high magnitude operational experience that occurred during a period of recent military deployment
  • Able to speak and read English and access to an internet-connected computer
  • Indication that the participant plans to be able to participant in the study for the next three months following the first assessment

You may not qualify if:

  • Diagnosis of bipolar disorder or psychotic disorder, as determined by participant self-report)
  • Current substance dependence, as determined by participant self-report)
  • Diagnosis of a moderate or severe traumatic brain injury, as determined by participant self-report)
  • Current suicidal ideation severe enough to warrant immediate attention, as determined by participant self-report)
  • Currently engaged in evidence-based treatment for PTSD (e.g. Prolonged Exposure Therapy or Cognitive Processing Therapy), as determined by participant self-report.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Center for the Treatment and Study of Anxiety, University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

University of Texas Health Science Center at San Antonio

San Antonio, Texas, 78229, United States

Location

Related Links

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticCombat DisordersWounds and Injuries

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Assistant Professor

Study Record Dates

First Submitted

November 3, 2017

First Posted

November 9, 2017

Study Start

February 12, 2018

Primary Completion

March 27, 2019

Study Completion

February 14, 2020

Last Updated

February 19, 2020

Record last verified: 2020-02

Locations